Shimadzu forms pact with Acuson

Article

The Japanese subsidiary of Acuson has chosen Shimadzu Corp. inKyoto as its exclusive sales agent in Japan for the moderatelypriced 128 XP/4 Advanced ultrasound scanner. The accord was formedin October and announced in the Japanese press in November.

The Japanese subsidiary of Acuson has chosen Shimadzu Corp. inKyoto as its exclusive sales agent in Japan for the moderatelypriced 128 XP/4 Advanced ultrasound scanner. The accord was formedin October and announced in the Japanese press in November.

Shimadzu officials will use the 128 XP/4 Advanced to fill aneed for a mid-tier color-flow system in its domestic productline, according to Yuji Shimizu, project leader of medical systemsmarketing at Shimadzu.

"We see this as an opportunity to expand our market share,"he said.

The alliance will enable Acuson to take advantage of Shimadzu'straditionally strong relationships with physicians in Japan'scommunity and public hospitals, said Judy Barton, Acuson's marketingmanager for Asia/Pacific and Latin American regions.

The manufacturer's Japanese subsidiary Acuson Nippon will continueto provide installation, training and service support for theXP/4 installed base, Barton said. It also spearheads Acuson'ssales of the high-performance 128 XP/10 to large hospitals anduniversity-based facilities in Japan, she said. No financial termswere disclosed.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.